Press Releases

BOTHELL, WA– November 16, 2011– SonoSite, Inc. (Nasdaq:SONO) , the world leader and specialist in bedside and point-of-care ultrasound, today announced the appointment of Richard Salzar as the Vice President and General Manager of Europe, Russia, and Africa.

“Richard is a strong leader with 30 years of experience in the healthcare industry,” said Kevin M. Goodwin, SonoSite’s President and CEO. “As we continue to position ourselves for growth in our international markets, Richard’s past success at the strategic and business level will further strengthen our ability to expand our international footprint. We anticipate optimally structuring our approach for improved execution and growth heading into 2012.”

“SonoSite is a unique company with a superior product line and long-term market opportunity,” said Richard Salzar. “I’m excited for the opportunity to join the company and I’m confident in my ability to leverage our current resources internationally and drive strong results in the coming years.”

BOTHELL, WA– November 15, 2011– SonoSite, Inc. (Nasdaq:SONO) , the world leader and specialist in bedside and point-of-care ultrasound, today announced the appointment of Brian Noyes as the Vice President of Marketing for North America and South America.

“Brian is an excellent addition to SonoSite and we welcome him to the leadership team,” said Matthew Damron, SonoSite’s Global Chief Marketing Officer. “He is an accomplished leader with decades of experience in the medical device industry, a successful product launch track record, and a key factor in the growth of a $1 billion franchise at Johnson & Johnson. Brian is a very appealing candidate to further elevate our marketing execution to the next level with expertise that is essential as we prepare to unleash the most exciting products in our company’s history.”

“SonoSite is a company with tremendous growth opportunities and has an enviable position in the healthcare industry,” said Brian Noyes. “I’m joining the company at a very exciting time, and I look forward to capitalizing on the current marketing initiatives, driving product demand, and market expansion.”

Revenues Hit $75.7 Million in the Quarter, Up 10%

Year-to-Date Revenues Reach $219.5 Million, Up 18%

Conference Call Webcast Live Today at 1:30 pm Pacific/4:30 pm Eastern

BOTHELL, WA - October 25, 2011 - SonoSite, Inc. (Nasdaq:SONO) , the world leader and specialist in bedside and point-of-care ultrasound, today reported financial results for the third quarter and nine months ended September 30, 2011.

REVENUE

Revenues for the third quarter of 2011 were $75.7 million, rising 10% in comparison to $68.5 million in the third quarter of 2010.

Revenues for the nine months of 2011 were $219.5 million, compared to $186.1 million in 2010, an increase of 18%.

Overall order booking rates increased 16% in the quarter.

Foreign exchange contributed to a 2.1% favorable impact on third quarter results and a 2.8% favorable impact on the first nine months of 2011.

EBITDAS, EBITDA and OPERATING INCOME (EBIT)

Third Quarter:

For the quarter, EBITDAS includes non-recurring severance charges of $1.3 million from SG&A cost restructuring. Operating expense run rate savings are projected at $6.0 million for 2012, positioning the company for improved operating margins while launching new products and driving marketing initiatives in 2012.

Sponsored by Mt. Sinai Hospital, The Louis J. Acompora Memorial Foundation, and The Dominic A. Murray 21 Memorial Foundation Free Screening October 22nd at Northport High School, Northport, New York

BOTHELL, WA - October 20, 2011 - SonoSite, Inc. (Nasdaq:SONO) , the world leader and specialist in bedside ultrasound for point-of-care medicine, proudly supports a community heart health screening to raise awareness and prevent sudden cardiac arrest in young adults.

Sponsored by the Louis J. Acompora Memorial Foundation , the Dominic A. Murray 21 Memorial Foundation and The Mount Sinai Hospital , the company will be providing physicians with its flagship M-Turbo ultrasound systems to perform a non-invasive cardiac ultrasound examination for the accurate evaluation of heart functionality, valve complications, and blood flow. Students between the ages of 14-24 are eligible for a free heart screening. The event will take place on October 22nd at the Northport High School in New York.

A Tool to Improve Post-Operative Surgical Outcomes and Reduce Hospital Costs

Non-invasive System to Assist in Fluid Management

Technology Debuts at the 2011 American Society of Anesthesiologists Conference (ASA) October 15-17th, Booth #2242

BOTHELL, WA - October 13, 2011 - SonoSite, Inc. (Nasdaq:SONO) , the world leader and specialist in bedside and point-of-care ultrasound, today introduced the new BioZ® Cardio Profile system with impedance cardiography (ICG) technology for non-invasively monitoring a patient's hemodynamic profile in the hospital. Pioneered by NASA in the 1960's, ICG hemodynamic monitoring has traditionally been used to treat patients with heart failure and hypertension, and it is now ready to play a significant role in the anesthesia suite.

BOTHELL, WA—October 6, 2011—SonoSite, Inc. (Nasdaq:SONO) , the world leader and specialist in bedside and point-of-care ultrasound, today announced that it will report the company's third quarter financial results on Tuesday, October 25, 2011 at the close of market and will host a conference call at 1:30 pm PT/4:30 ET. The call will be broadcast live and can be accessed via SonoSite's website at http://www.sonosite.com/about/investors .

A replay of the audio webcast will be available beginning October 25th at 4:30 pm PT and will be available until November 8th at 9:59 pm PT by dialing (719) 457-0820 or toll-free (888) 203-1112. The confirmation code 7745091 is required to access the replay. The call will also be archived on SonoSite's website.

About SonoSite

SonoSite, Inc. ( www.sonosite.com ) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.

BOTHELL, WA - August 11, 2011 - SonoSite, Inc. (Nasdaq:SONO) , the world leader and specialist in bedside and point-of-care ultrasound, today announced the appointment of Mehran Mehrtash as Vice President and General Manager of Asia Pacific and the Middle East. Mr. Mehrtash's appointment will aid in the further development of the Asia Pacific region and the company's plans to expand its footprint in China and South Korea; two emerging markets with high growth potential.

"I am excited to welcome Mehran to the SonoSite team, said Mr. Kevin M. Goodwin, SonoSite's President and CEO. "He has a successful track record in the Asia Pacific region and his addition is imperative as we sharpen our focus on expanding in China and South Korea. With an existing appetite for new and innovative technology in these markets, I am confident that Mehran's leadership will enable the company to hit our growth targets."

Conference Call Webcast Live Today at 1:30 pm Pacific/4:30 pm Eastern

BOTHELL, WA – July 25, 2011 – SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today reported financial results for the second quarter ended June 30, 2011.

REVENUE Revenue for the second quarter of 2011 was $72.7 million, an increase of 18% compared to $61.5 million in the second quarter of 2010.

Revenue for the first half of 2011 was $143.8 million compared to $117.5 million in 2010, an increase of 22%.

Revenue from VisualSonics (VSI), Inc. was $8.3 million for the quarter, up 7%. Revenues were $16.5 million for the first half of 2011, up 5%.

Foreign exchange contributed to a 4% favorable impact on second quarter results and a 3% favorable impact on the first half of 2011.

Revenues were also negatively impacted in the second quarter by a series of delayed orders between $4.0-$5.0 million.

SECOND QUARTER, FIRST HALF, AND MARKETING MILESTONES

Increased Use of Bedside Ultrasound Drives Remarkable Patient Outcomes: Zero Incidents of a Common Complication - Iatrogenic Pneumothorax (Collapsed Lung) - for Up to 36 Months

BOTHELL, WA - July 21, 2011 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside ultrasound for point-of-care medicine, congratulates Memorial Herman Healthcare System (Memorial Hermann), one of the Nation's largest non-profit healthcare systems, for its excellence in delivering the highest level of patient safety by achieving "inspiring" safety results previously never thought possible. Four years ago, Memorial Hermann instituted a network-wide patient safety initiative as a part of its "journey to providing high reliability healthcare" and to meet national patient safety goals. To reward safety success stories, the healthcare system created a "Certified Zero High Reliability Award" acknowledging facilities that achieved a zero complication rate for a full-year or more for certain events and procedures. By introducing new safety...

Chief Operating Officer, Jack Sparacio

Global Chief Marketing Officer, Matthew Damron